Organization | IL Sogno di Stefano

IL Sogno di Stefano Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial

2000

NCT00161330

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2013

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 3 Trials (6)

cefixime (suprax) (1 trial)

ceftriaxone (rocephin) (1 trial)

clavulanate (Augmentin) (2 trials)

nitrofurantoin (furadantin) (1 trial)

procaine benzylpenicillin (novocaine) (2 trials)

trimethoprim (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Communicable Diseases (Phase 3)

Congenital Abnormalities (Phase 3)

Infections (Phase 3)

Kidney Diseases (Phase 3)

Renal Insufficiency, Chronic (Phase 3)

Urinary Tract Infections (Phase 3)

Vesico-Ureteral Reflux (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 2
# of Trial APIs: 6